<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02155179</url>
  </required_header>
  <id_info>
    <org_study_id>semen-esd</org_study_id>
    <nct_id>NCT02155179</nct_id>
  </id_info>
  <brief_title>Sperm Pathology Samples and Morphokinetics</brief_title>
  <official_title>Embryo Kinetics and Sperm Quality. Depends on the Sperm Quality the Embryo Cleavage Rate?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IVI Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IVI Madrid</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The embryo kinetics may be a new prognostic factor for choosing the embryos with the highest
      implantation potential. In order to identify the factors that may affect the rate of embryo
      cleavage, there are many studies about morphokinetics and culture medium, oxygen tension,
      oocyte quality or type of medication used for ovarian stimulation. However there are no
      published data with respect to the influence of semen quality in the embryo kinetic.

      In this study The investigators propose that the sperm quality may has influence in the
      embryo division.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Actual">December 2018</completion_date>
  <primary_completion_date type="Actual">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>embryo division in 2, 3, 4, 5, 6, 7, 8, cells and blastocyst formation</measure>
    <time_frame>between day 0 and day 5 of development</time_frame>
    <description>Exact time of cell cleavages</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">112</enrollment>
  <condition>Cylinical Embryo</condition>
  <condition>Oligospermia</condition>
  <arm_group>
    <arm_group_label>Good prognosis</arm_group_label>
    <description>Sperm samples &gt;15mill/ml &gt;30% progresive sperms</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bad prognosis</arm_group_label>
    <description>Sperm samples &lt;5mill/ml &lt;5% progresive sperms</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Sperms samples of assisted reproduction treatments
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sperm samples with more than 15 mill/ml of sperms, more than 40% of mobile sperms

          -  Sperm samples with less than 5 mill/ml of sperms, less than 10% of mobile sperms

        Exclusion Criteria:

          -  sperm samples between 5 to 15 mil/ml of sperms and between 10% to 40% of mobile sperms
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>david agudo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>lab coordinator</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IVI MAdrid</name>
      <address>
        <city>Madrid</city>
        <zip>28023</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>June 2, 2014</study_first_submitted>
  <study_first_submitted_qc>June 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2014</study_first_posted>
  <last_update_submitted>August 12, 2019</last_update_submitted>
  <last_update_submitted_qc>August 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oligospermia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

